Press Releases Aurobindo Pharma

Equities

Market Closed - NSE India S.E. Other stock markets 07:43:47 2024-05-09 EDT			5-day change	1st Jan Change
1,115 ^INR	-1.83%		-3.55%	+2.89%

05-08	India's Hindalco mulls seeking $1.2 bln in Novelis IPO, Bloomberg News reports	RE
05-02	Aurobindo Pharma Completes Sale of US Arm's Business Assets	MT

Maintainability Of Sister Ship Arrest On The Premise That Both Vessels Are Managed/operated By The Same Entity, While Each Ship Is Owned By Distinct One Ship Company – Bombay High Court	04-29	AQ
Aurobindo Pharma : Q2 – UFR 2023-24	11-08	PU
Aurobindo Pharma : Q2FY24	23-10-31	PU
Aurobindo Pharma : PR-Q1 FY 2023-24	23-08-14	PU
Aurobindo Pharma : Earnings Presentation-Q1 FY 2023-24	23-08-14	PU
Aurobindo Pharma : Q1 – UFR 2023-24	23-08-14	PU
Aurobindo Pharma : Annual CSR Report 2022-23	23-08-08	PU
Aurobindo Pharma : Q1FY24	23-08-04	PU
Aurobindo Pharma : Annual Report 2022-23	23-08-02	PU
Aurobindo Pharma : Q4 – AFR 2022-23	23-05-26	PU
Aurobindo Pharma : Q4FY23	23-05-19	PU
Aurobindo Pharma : Earnings Presentation-Q3 FY 2022-23	23-02-09	PU
Aurobindo Pharma : Q3FY23	23-02-03	PU
Aurobindo Receives FDA Approval for Emzahh 0.35mg	23-01-11	AQ
Aurobindo Receives FDA Approval for Ursodiol Capsules USP, 300mg	22-12-01	AQ
Aurobindo Receives FDA Approval for Carbidopa and Levodopa Tablets	22-11-30	AQ
Aurobindo Pharma : Earnings Presentation-Q2 FY 2022-23	22-11-14	PU
Aurobindo Pharma : PR-Q2 FY 2022-23	22-11-14	PU
Aurobindo Receives FDA Approval for Dicloxacillin Sodium Capsules USP, 250mg and 500mg	22-09-27	AQ
Aurobindo Pharma : Q1FY2023 – Earning call transcript	22-08-19	PU

No results for this search